Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEOutcome of Board Meeting▲ PositiveResults8 Aug 2026

Nitin Spinners Limited

Outcome of Board Meeting

Nitin Spinners Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, with the company's board of directors approving the results and recommending the re-appointment of a non-executive independent director. The results show a profit before tax of Rs. 10,097.63 lakhs and an earnings per share of Rs. 13.39.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults8 Aug 2026

Nitin Spinners Ltd

Outcome of Board Meeting held on 08.08.2026

Nitin Spinners Ltd announced unaudited financial results for the quarter ended 30th June, 2026. The company reported a profit of Rs. 10,097.63 lakhs, with revenue from operations at Rs. 87,503.04 lakhs and total expenses at Rs. 77,649.76 lakhs. The company also recommended the re-appointment of Sh. Rohit Swadheen Mehta as a Non-Executive Independent Director for a second term. The trading window for the company's shares will open from August 11, 2026.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults8 Aug 2026

C.E. Info Systems Limited

Analysts/Institutional Investor Meet/Con. Call Updates

C.E. Info Systems Limited has announced its Q1FY2027 earnings, with revenue up 14.9% YoY to INR139.7 crores, EBITDA at INR56.1 crores, and PAT up 8.6% to INR49.7 crores. The company has also changed its market segment framework to Automotive, Enterprise, and Government.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults8 Aug 2026

C.E. Info Systems Ltd

Q1FY27 Earning Call Transcript

C.E. Info Systems Ltd, a multi-product and multi-industry company, has reported Q1FY27 revenue of INR139.7 crores, up 14.9% year-on-year, with EBITDA margin at 40.2% and PAT margin at 31.2%. The company has also announced the appointment of Rohan Verma as Joint Managing Director and is leaning heavily into AI for product development and offerings.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults8 Aug 2026

Eveready Industries India Ltd

Investors Presentation

Eveready Industries India Ltd has announced its Q1 FY27 investor presentation, showcasing a 9.0% YoY revenue growth, with commercial operations of the Jammu plant started on 29th May. The company has also launched a new product innovation with a first-of-its-kind, patent-applied portable-liquid-vaporizer with rechargeable lithium-ion battery and hybrid flashlights. The presentation highlights double-digit growth in batteries, led by 56% alkaline and 8% Carbon Zinc growth. The company has also reported a 9.4% operational highlights with YoY quarterly revenue growth of 9.0%.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults8 Aug 2026

Eveready Industries India Ltd

Press Release

Eveready Industries India Ltd reported unaudited financial results for Q1 FY27, with revenue up 9% YoY and EBITDA margin at 15.1%. The company marked its seventh consecutive quarter of revenue growth, driven by strong alkaline battery performance and a recovery in carbon zinc batteries.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults8 Aug 2026

Eveready Industries India Limited

Press Release

Eveready Industries India Limited has announced its unaudited financial results for the quarter ended 30 June 2026, with revenue up 9% YoY and EBITDA margin at 15.1%. The company has maintained stable EBITDA margins despite inflation in commodities and other input costs.

Read more →📎 1 attachment
BSECompany Update▲ PositiveExpansion8 Aug 2026

Radico Khaitan Ltd

Investor Presentation titled "Taking India to the World".

Radico Khaitan Ltd, a leading spirits company in India, presented its investor relations document 'Taking India to the World' in August 2026. The document highlights the company's growth prospects in the Indian spirits market, driven by favorable demographics, premiumization trends, and strong structural growth drivers. The company expects the IMFL (Indian Made Foreign Liquor) sales volume to grow at a CAGR of 3.5% and sales value at 6.8% during the CY2025-30 period.

Read more →📎 1 attachment
NSEUpdates▲ PositiveExpansion8 Aug 2026

Radico Khaitan Limited

Updates

Radico Khaitan Limited has released an investor presentation titled 'Taking India to the World', highlighting the company's growth prospects in the Indian spirits industry, driven by premiumization, favorable demographics, and strong demand for premium and above brands.

Read more →📎 1 attachment
BSECompany Update▲ PositiveExpansion8 Aug 2026

Signatureglobal (India) Ltd

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Collaboration Agreements have been entered into by the Company and Signatureglobal ....

Signatureglobal (India) Ltd has entered into collaboration agreements for land parcels in Sohna, District Gurugram, Haryana, with development rights for a real estate project. The lands have an overall potential developable area of approximately 2.18 million square feet.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults8 Aug 2026

Prithvi Exchange (India) Ltd

Investor Presentation is attached

Prithvi Exchange (India) Ltd has released its Q1 FY2026-27 investor presentation, highlighting positive growth across all business verticals, successful beta launch of Prithvi-branded multi-currency Forex Cards, and expansion of cash to master (CTM) business.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults8 Aug 2026

Prithvi Exchange (India) Ltd

Press Release attached

Prithvi Exchange (India) Ltd reported Q1 FY2026-27 financial results with a 28.9% year-on-year growth in total revenue to ₹1,10,471.85 lakh and a net profit of ₹70.90 lakh, compared to a net loss of ₹36.62 lakh in Q4 FY26.

Read more →📎 1 attachment
BSECompany Update▲ PositiveM&A8 Aug 2026

Advanced Enzyme Technologies Ltd

1) Approved acquistion of the remaining stake of 4.28% Equity Shares from the other existing Equity Shareholders of JC Biotech Private Limited (Exisitng Subsidiary) and 2) Approved infusion ....

Advanced Enzyme Technologies Ltd approved the acquisition of the remaining stake of 4.28% Equity Shares from the other existing Shareholders of JC Biotech Private Limited and approved infusion of additional funds not exceeding ₹ 20 million in Advanced Nutrazyme Private Limited. The company also approved the buyback of fully paid-up equity shares having a face value of ₹ 2/- each at a price not exceeding ₹ 500/- per equity share.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults8 Aug 2026

Advanced Enzyme Technologies Limited

Outcome of Board Meeting

Advanced Enzyme Technologies Limited has informed the Exchange regarding Outcome of Board Meeting held on August 08, 2026. The Board has approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026. Additionally, the Board has approved the Buyback of fully paid-up equity shares having a face value of ? 2/- (Rupees Two only) each of the Company at a price not exceeding ? 500/- (Rupees Five Hundred only) per equity share. The Board has also approved the acquisition of the remaining stake of 4.28% Equity Shares from the other existing Shareholders of JC Biotech Private Limited and the infusion of additional funds not exceeding ? 20 million in Advanced Nutrazyme Private Limited.

Read more →📎 1 attachment
BSEOthers▲ PositiveResults8 Aug 2026

Tips Music Ltd

Annual Report for the financial year 2025-26

Tips Music Ltd has announced its annual report for the financial year 2025-26, with a 19.6% revenue growth and 30% EPS growth. The company has returned Rs 166.18 crores to its shareholders through dividends and ended the year with a Cash and cash equivalent balances of Rs 267 crores.

Read more →📎 1 attachment
BSEResult▲ PositiveResults8 Aug 2026

Advanced Enzyme Technologies Ltd

Un-audited Financial Results for the Quarter ended June 30, 2026

Advanced Enzyme Technologies Ltd has announced unaudited financial results for the quarter ended June 30, 2026, and approved a buyback of up to 1,394,000 equity shares at a maximum price of ₹500 per share, and also approved the acquisition of the remaining stake of 4.28% in JC Biotech Private Limited and infusion of additional funds in Advanced Nutrazyme Private Limited.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults8 Aug 2026

Advanced Enzyme Technologies Limited

Outcome of Board Meeting

Advanced Enzyme Technologies Limited has submitted its financial results for the quarter ended June 30, 2026, and approved a buyback of equity shares, acquisition of a remaining stake in JC Biotech Private Limited, and infusion of additional funds in Advanced Nutrazyme Private Limited.

Read more →📎 1 attachment
← PreviousPage 693 of 992Next →